Haleon plc
HLNNYSEHealthcareDrug Manufacturers - Specialty & Generic

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Stock Details

ExchangeNYSE (NYSE)
CurrencyGBP - GBP
TypeStock

Contact Information

Phone44 1932 959 500
Address
The Heights, Building 5, First Floor Weybridge, KT13 0NY United Kingdom

Corporate Identifiers

CIK0001900304
CUSIP405552100
ISINUS4055521003
SIC2844

Leadership Team & Key Executives

Brian James McNamara
Chief Executive Officer and Executive Director
Dawn Amanda Allen
Chief Financial Officer and Director
Claire Dickson
Chief Digital and Technology Officer
Joanne Russell
Head of Investor Relations
Adrian Charles Morris
General Counsel
Tamara Rogers
Chief Marketing Officer
Line De Decker
Chief Human Resources Officer
Filippo Lanzi
President of EMEA and LatAm
Keith Choy
President of Asia Pacific
Lisa Paley
President of North America